Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 24, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Scabies; ItchScabies
Interventions
DRUG

Ivermectin Tablets

"ITCHY Study:~All participants will receive one dose of oral ivermectin 3mg on day 0 and have two blood samples taken to determine the serum ivermectin concentrations after the dose. Timing of blood samples will vary depending on the allocated group.~ITCHY2 Study:~Participants will receive one age-specific dose of oral ivermectin on day 0 and have two blood samples taken to determine the serum ivermectin concentrations after the dose. Timing of blood samples will vary depending on the allocated group.~Age specific ivermectin dose:~* 0.75mg of ivermectin will be given to participants aged 3 to 7 months~* 1.5mg of ivermectin will be given to participants aged 8 to 12 months~* 3mg of ivermectin will be given to participants aged 13 to 24 months"

Trial Locations (5)

Unknown

RECRUITING

Banchieng Health Centre, Kasy District

RECRUITING

Hinngoon Health Centre, Kasy District

RECRUITING

Kasy District Hospital, Kasy District

RECRUITING

Poonglack Health Centre, Kasy District

RECRUITING

ThongMeud Health Centre, Kasy District

Sponsors
All Listed Sponsors
lead

Murdoch Childrens Research Institute

OTHER

collaborator

Burnet Institute

OTHER

collaborator

Lao Tropical and Public Health Institute

OTHER_GOV